Skip to content

Application of Corail Revision Femoral Stem in Paprosky III Hip Revision

Application of Corail Revision Femoral Stem in Paprosky III Hip Revision

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045424
Enrollment
Unknown
Registered
2021-04-14
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hip disease

Interventions

Corail Revision femoral stem group:Null

Sponsors

PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Subjects are between 65 and 80 years old; 2. Subjects have normal bone development; 3. Subjects had indications for revision hip surgery and were classified as Paprosky III; 4. Subjects are willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. The subject is due to neuromuscular insufficiency; 2. The subject is mentally incapable or unable to understand the requirements for study participation; 3. Alcoholics or drug addicts or substance abusers; 4. Obesity BMI > 35; 5. Poor control of blood glucose and blood pressure; 6. The subject has a history of allergy to the implanted materials; 7. Active infection of hip joint; 8. Severe bone disease and tumor around hip joint; 9. The life expectancy of patients who cannot tolerate surgery for other systemic diseases is less than 2 years; 10. Subjects were still participating in other clinical studies before being enrolled; 11. Other diseases associated with the subjects could not cooperate with the follow-up; 12. Poor compliance of subjects; 13. Other circumstances deemed inappropriate for this clinical trial.

Design outcomes

Primary

MeasureTime frame
Hip function score;Radiographic data;

Secondary

MeasureTime frame
Length of stay;The satisfaction of patients;

Countries

China

Contacts

Public ContactZhang Guoqiang

PLA General Hospital

gqzhang301@163.com+86 13601210743

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026